Shanghai Shenqi Pharmaceutical Investment Management Co Ltd - Class A

SHSE:600613 (China)   Class A
Â¥ 6.78 (-1.74%) May 10
61.64
P/B:
1.53
Market Cap:
Â¥ 3.50B ($ 483.80M)
Enterprise V:
Â¥ 2.98B ($ 412.19M)
Volume:
7.45M
Avg Vol (2M):
7.17M
Volume:
7.45M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd ( ) from 1992 to May 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shanghai Shenqi Pharmaceutical Investment Management stock (SHSE:600613) PE ratio as of May 12 2024 is 61.64. More Details

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (SHSE:600613) PE Ratio (TTM) Chart

To

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (SHSE:600613) PE Ratio (TTM) Historical Data

Total 1184
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Shanghai Shenqi Pharmaceutical Investment Management PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-12 61.6 2024-03-05 57.5
2024-05-10 61.6 2024-03-04 59.5
2024-05-09 62.7 2024-03-01 57.2
2024-05-08 61.7 2024-02-29 57.2
2024-05-07 61.3 2024-02-28 55.7
2024-05-06 61.1 2024-02-27 59.7
2024-04-30 59.4 2024-02-26 58.5
2024-04-29 58.7 2024-02-23 57.8
2024-04-26 57.3 2024-02-22 58.1
2024-04-25 57.4 2024-02-21 57.1
2024-04-24 56.4 2024-02-20 57.6
2024-04-23 54.8 2024-02-19 52.4
2024-04-22 54.5 2024-02-16 50.9
2024-04-19 54.1 2024-02-09 50.9
2024-04-18 53.8 2024-02-08 50.9
2024-04-17 55.4 2024-02-07 46.4
2024-04-16 51.2 2024-02-06 47.9
2024-04-15 55.1 2024-02-05 46.3
2024-04-12 57.6 2024-02-02 51.4
2024-04-11 59.5 2024-02-01 54.4
2024-04-10 59.4 2024-01-31 56.3
2024-04-09 60.5 2024-01-30 59.8
2024-04-08 58.4 2024-01-29 61.5
2024-04-05 61.2 2024-01-26 63.5
2024-04-03 61.2 2024-01-25 62.8
2024-04-02 60.5 2024-01-24 60.3
2024-04-01 60.5 2024-01-23 59.1
2024-03-29 58.8 2024-01-22 58.8
2024-03-28 58.9 2024-01-19 63.1
2024-03-27 58.0 2024-01-18 63.9
2024-03-26 58.8 2024-01-17 64.7
2024-03-25 58.7 2024-01-16 66.6
2024-03-22 60.5 2024-01-15 67.2
2024-03-21 61.8 2024-01-12 66.5
2024-03-20 62.1 2024-01-11 67.3
2024-03-19 61.3 2024-01-10 65.9
2024-03-18 61.4 2024-01-09 66.8
2024-03-15 59.8 2024-01-08 66.7
2024-03-14 59.3 2024-01-05 67.9
2024-03-13 59.5 2024-01-04 69.2
2024-03-12 59.8 2024-01-03 69.7
2024-03-11 58.7 2024-01-02 69.5
2024-03-08 57.6 2023-12-29 69.2
2024-03-07 57.0 2023-12-28 68.2
2024-03-06 57.4 2023-12-27 67.5

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (SHSE:600613) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

ISIN : CNE000000453

Share Class Description:

SHSE:600613: Class A
Description
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is mainly engaged in pharmaceutical production and distribution in China.